Brief: Annexin Pharmaceuticals Appoints Anders Haegerstrand CEO
Oct 8 (Reuters) - Annexin Pharmaceuticals AB (publ)
ANNX.ST :
* ANDERS HAEGERSTRAND APPOINTED CEO
* ANDERS HAEGERSTRAND REPLACES JAMAL EL-MOSLEH AS CEO
* CEO APPOINTMENT EFFECTIVE IMMEDIATELY
Source text for Eikon: ID:nWkr79MzSv
Further company coverage: ANNX.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Annexin Pharmaceuticals AB (publ)
See all newsBrief: Annexin Pharmaceuticals Q3 Net Loss At SEK 9.5 Mln
Brief: Annexin Pharmaceuticals Q2 2026 Net Loss SEK 11.6 Mln
Brief: Annexin Pharmaceuticals Gets International Nonproprietary Name Drug Candidate Anxv
Brief: Annexin Pharmaceuticals Updates On Nine Patients Treated In Nexus Study
Brief: Annexin's Rights Issue 98% Subscribed